ABIOMED, Inc. - Common Stock (NQ:ABMD)

N/A UNCHANGED

Last Price Updated: 4:00 PM EST, Dec 21, 2022 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ABIOMED, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Risk Vs Reward Vs Folly: Navigating Investment Choices ↗

September 29, 2023

During the dot-com era, many individuals ridiculed Buffett for his refusal to invest in ventures that contradicted his principles. Years later, the majority of these so-called experts, if not all of...

Via Talk Markets

Is It Too Late to Buy Johnson & Johnson's Stock? ↗

April 28, 2023

This healthcare juggernaut's recent quarterly results prove just how strong its business is.

Via The Motley Fool

2 Best Buffett Stocks to Buy for the Long Haul ↗

December 27, 2022

Both of these stocks look like bargains right now.

Via The Motley Fool

FDA Approves Impella ECP Pivotal Heart Pump and First Patients Enrolled in Pivotal Clinical Trial

December 21, 2022

From Abiomed, Inc.

Via Business Wire

If You Invested $100 In This Stock 10 Years Ago, You Would Have $2,800 Today ↗

December 08, 2022

Via Benzinga

Here's How Much You Would Have Made Owning Abiomed Stock In The Last 15 Years ↗

November 21, 2022

Via Benzinga

Will Investors Notice Exciting Sign On Abiomed's Chart? ↗

November 16, 2022

Via Benzinga

Interest Rate Hikes Won't Stop These 2 Cash-Rich Growth Stocks ↗

December 21, 2022

Even if interest rates go up, you likely won't need to worry about these stocks.

Via The Motley Fool

The Best Stocks to Invest $20,000 in Right Now ↗

December 21, 2022

The investments you make now could power your portfolio returns for years to come.

Via The Motley Fool

Warren Buffett Loves These Stocks. Should You Buy Them Before 2023? ↗

December 16, 2022

There's a lot more ahead for these market giants.

Via The Motley Fool

Pfizer, Novartis Are Among Overbought Healthcare Stocks: Are They Worth A Look? ↗

December 14, 2022

The most overbought stocks in the healthcare sector presents an opportunity to go short on these overvalued companies. Here’s the latest list of major overbought players in this sector, with an RSI...

Via Benzinga

2 Top Dividend Kings to Buy for the Long Haul ↗

December 14, 2022

No matter how much changes, these two healthcare giants keep performing.

Via The Motley Fool

Can Pfizer, Johnson & Johnson Continue Outperforming the Index?

December 09, 2022

Large-cap pharmaceuticals Pfizer and Johnson & Johnson are outperforming the broader market in the past year, particularly in the past three months.

Via MarketBeat

This Monster Dividend Stock Isn't Done Growing ↗

December 08, 2022

Is another deal on the way for Johnson & Johnson?

Via The Motley Fool

Horizon Topples After J&J Pulls Out Of Bidding War, Leaving Amgen, Sanofi ↗

December 05, 2022

There are now two companies in the ring for a Horizon takeover.

Via Investor's Business Daily

First Patients in the World Treated with Impella RP Flex with SmartAssist

December 05, 2022

From Abiomed, Inc.

Via Business Wire

3 Healthcare Stocks to Buy and Hold for the Next 10 Years ↗

December 02, 2022

This space is ripe with opportunities for investors.

Via The Motley Fool

Analyst Forecasts $101-117/Share Offer Price For Horizon Therapeutics' Buyout ↗

November 30, 2022

Via Benzinga

Bear Market Blues? 3 of the Best Stocks to Own in 2023 ↗

November 19, 2022

2023 could be a big year for each of these healthcare companies.

Via The Motley Fool

Peering Into Abiomed's Recent Short Interest ↗

November 17, 2022

Abiomed's (NASDAQ:ABMD) short percent of float has risen 6.62% since its last report. The company recently reported that it has 2.08 million shares sold short, which is 5.96% of all regular shares that...

Via Benzinga

ABIOMED INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Abiomed, Inc. - ABMD

November 16, 2022

From Kahn Swick & Foti, LLC

Via Business Wire

S&P 500 Component DexCom Set For Further Price, Earnings Growth

November 13, 2022

Glucose monitor maker DexCom surged 19% after its Q3 report, and shares are holding those gains. Wall Street sees more growth ahead in 2023.

Via MarketBeat

Topics Stocks

2 Warren Buffett Passive Income Stocks You Can Buy to Boost Your Yield ↗

November 11, 2022

Buffett loves stocks that pay dividends. Is it any wonder Berkshire Hathaway is poised to collect more than $6 billion worth of them next year?

Via The Motley Fool

Better Buy: Johnson & Johnson vs. Abbott Laboratories ↗

November 10, 2022

These two healthcare giants are among the safest stocks investors can buy right now.

Via The Motley Fool

Johnson & Johnson Could Level Up With Its $16.8 Billion Purchase of Abiomed ↗

November 10, 2022

The company is planting seeds for future growth.

Via The Motley Fool

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) Oyster Point Pharma, Inc. (Nasdaq - OYST), Benefitfocus, Inc. (Nasdaq - BNFT), Abiomed, Inc. (Nasdaq - ABMD), Atlas Corp. (NYSE - ATCO)

November 08, 2022

From Brodsky & Smith LLC

Via GlobeNewswire

2 Healthcare Stocks You Can Buy and Hold for the Next Decade ↗

November 08, 2022

These robust businesses will be around well beyond the next 10 years.

Via The Motley Fool

3 No-Brainer Stocks to Buy in a Downturn ↗

November 08, 2022

These companies thrive when others falter.

Via The Motley Fool

Johnson & Johnson's Big Purchase, Amazon's New Moves, and More ↗

November 05, 2022

Plus, we run through some shortcuts that could help you with your financial planning.

Via The Motley Fool

Is Johnson & Johnson's Purchase of Abiomed Good for Investors? ↗

November 05, 2022

The $16.6 billion acquisition shakes up MedTech.

Via The Motley Fool

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.